Article
Recombinant synthesis, purification, and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product.
The Journal of biological chemistry - 5 Apr 1992
Hartman J, Huang Z, Rado T A, Peng S, Jilling T, Muccio D D, Sorscher E J
Abstract excerpt
The majority of mutations which lead to clinical cystic fibrosis are located within the two predicted nucleotide binding domains of the cystic fibrosis gene product. We have used a prokaryotic expression system to synthesize and purify the first nucleotide binding domain (NBD-1, amino acids 426-588) with and without the most common mutation associated with the disease (the deletion of phenylalanine at position...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
